{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:22:52Z","timestamp":1792592572991,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010716","name":"Stadt Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jtha.2024.07.034","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T17:41:17Z","timestamp":1724866877000},"page":"3209-3220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fibrinolysis is impaired in patients with primary immune thrombocytopenia"],"prefix":"10.1016","volume":"22","author":[{"given":"Theresa","family":"Schramm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Rast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Mehic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie E.","family":"Reitsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"de Moreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fillitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa S.","family":"Wolberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Gebhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.07.034_bib1","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.034_bib2","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.034_bib3","first-page":"16","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.07.034_bib4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3324\/haematol.2009.018390","article-title":"Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database","volume":"95","author":"Sarpatwari","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.07.034_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.hoc.2013.03.001","article-title":"Immune thrombocytopenia","volume":"27","author":"Kistangari","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jtha.2024.07.034_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.24234","article-title":"Is ITP a thrombophilic disorder?","volume":"91","author":"Rodeghiero","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2024.07.034_bib7","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/bloodadvances.2017007989","article-title":"ITP and thrombosis: an intriguing association","volume":"1","author":"Rodeghiero","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.07.034_bib8","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.07.034_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2023.01.012","article-title":"Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia","volume":"223","author":"Mehic","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.034_bib10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/bjh.14412","article-title":"Procoagulant profile in patients with immune thrombocytopenia","volume":"175","author":"\u00c1lvarez-Rom\u00e1n","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.07.034_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/09537104.2019.1639655","article-title":"Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists","volume":"31","author":"Garabet","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2024.07.034_bib12","first-page":"5987","article-title":"Clot waveform analysis demonstrates low blood coagulation ability in patients with idiopathic thrombocytopenic purpura","volume":"10","author":"Wada","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.07.034_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/s-0039-1678706","article-title":"Platelet apoptosis and PAI-1 are involved in the pro-coagulant state of immune thrombocytopaenia patients treated with thrombopoietin receptor agonists","volume":"119","author":"Justo Sanz","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.034_bib14","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/bjh.18702","article-title":"IVIg treatment increases thrombin activation of platelets and thrombin generation in paediatric patients with immune thrombocytopenia","volume":"201","author":"Schmugge","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.07.034_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/ATVBAHA.110.213371","article-title":"Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences","volume":"31","author":"Smalberg","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.07.034_bib16","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2009-05-222380","article-title":"Altered fibrin clot structure\/function in patients with idiopathic venous thromboembolism and in their relatives","volume":"114","author":"Undas","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.034_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8196256","article-title":"Prothrombotic fibrin clot phenotype in patients with deep vein thrombosis and pulmonary embolism: a new risk factor for recurrence","volume":"2017","author":"Undas","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jtha.2024.07.034_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12933-017-0515-9","article-title":"Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk","volume":"16","author":"Kearney","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jtha.2024.07.034_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12933-021-01372-w","article-title":"Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation","volume":"20","author":"Bryk-Wi\u0105zania","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jtha.2024.07.034_bib20","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0002-8703(98)70149-8","article-title":"Hypofibrinolysis in atrial fibrillation","volume":"136","author":"Rold\u00e1n","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2024.07.034_bib21","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/ATVBAHA.120.314514","article-title":"Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses","volume":"40","author":"Mackman","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.07.034_bib22","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/ijms22052758","article-title":"Assessing plasmin generation in health and disease","volume":"22","author":"Miszta","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2024.07.034_bib23","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood.2019004267","article-title":"A\u00a0high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice","volume":"135","author":"Miszta","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.034_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100774","article-title":"Hemostatic changes by thrombopoietin-receptor agonists in immune thrombocytopenia patients","volume":"47","author":"van Dijk","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2024.07.034_bib25","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1111\/bjh.16164","article-title":"Evolution of platelet function in adult patients with chronic immune thrombocytopenia on romiplostim treatment","volume":"187","author":"Ignatova","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.07.034_bib26","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/01.ATV.14.9.1452","article-title":"Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop","volume":"14","author":"Stringer","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jtha.2024.07.034_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/09537104.2017.1394451","article-title":"Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia","volume":"30","author":"Garabet","year":"2019","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2024.07.034_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000529662","article-title":"Expert report on immune thrombocytopenia: current diagnostics and treatment - recommendations from an expert group from Austria, Germany, and Switzerland","volume":"46","author":"Matzdorff","year":"2023","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.jtha.2024.07.034_bib30","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2012-07-442392","article-title":"Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group","volume":"121","author":"Rodeghiero","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.034_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/bio.2018.0032","article-title":"Usage data and scientific impact of the prospectively established fluid bioresources at the hospital-based MedUni Wien Biobank","volume":"16","author":"Haslacher","year":"2018","journal-title":"Biopreserv Biobank"},{"key":"10.1016\/j.jtha.2024.07.034_bib32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/jth.14002","article-title":"An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH","volume":"16","author":"Pieters","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.034_bib33","first-page":"7249","article-title":"Comparison of current international guidelines for the management of dyslipidemia","volume":"11","author":"Aygun","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.07.034_bib34","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.07.034_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00508-012-0123-3","article-title":"Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (OGHO)","volume":"124","author":"Pabinger","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jtha.2024.07.034_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/bjh.12118","article-title":"Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts","volume":"160","author":"Larsen","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.07.034_bib37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1160\/TH13-04-0345","article-title":"Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis","volume":"110","author":"Matsumoto","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.034_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1179\/102453311X13085644680348","article-title":"A\u00a0novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis","volume":"16","author":"van Geffen","year":"2011","journal-title":"Hematology"},{"key":"10.1016\/j.jtha.2024.07.034_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jth.15114","article-title":"Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery","volume":"19","author":"Miszta","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.034_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.thromres.2010.12.011","article-title":"Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults","volume":"127","author":"Simpson","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.034_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11239-019-01869-y","article-title":"Contradictory to its effects on thrombin, C1-inhibitor reduces plasmin generation in the presence of thrombomodulin","volume":"48","author":"Tarandovskiy","year":"2019","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.07.034_bib42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00001721-199509000-00011","article-title":"Effect of fibrin structure on plasmin-mediated dissolution of plasma clots","volume":"6","author":"Carr","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.07.034_bib43","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.ATV.20.5.1354","article-title":"Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy","volume":"20","author":"Collet","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.07.034_bib44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2010-06-290338","article-title":"The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies","volume":"117","author":"Longstaff","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.034_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.actbio.2022.01.006","article-title":"Microscale structural changes of individual fibrin fibers during fibrinolysis","volume":"141","author":"Lynch","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jtha.2024.07.034_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/imammb\/dqs030","article-title":"Modelling fibrinolysis: 1D continuum models","volume":"31","author":"Bannish","year":"2014","journal-title":"Math Med Biol"},{"key":"10.1016\/j.jtha.2024.07.034_bib47","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.3390\/ijms22063170","article-title":"PAI-1 in diabetes: pathophysiology and role as a therapeutic target","volume":"22","author":"Altalhi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2024.07.034_bib48","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.V69.2.381.381","article-title":"Plasminogen activator inhibitors","volume":"69","author":"Sprengers","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.034_bib49","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2174\/1389450120666190715102510","article-title":"Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis","volume":"20","author":"Urano","year":"2019","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jtha.2024.07.034_bib50","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.CIR.96.3.761","article-title":"Clearance of tissue plasminogen activator (TPA) and TPA\/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels","volume":"96","author":"Chandler","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.07.034_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.thromres.2004.12.007","article-title":"The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project","volume":"116","author":"Nordenhem","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.034_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.ATV.19.3.493","article-title":"Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study","volume":"19","author":"Cushman","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.07.034_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2018.02.135","article-title":"Role of plasminogen activator inhibitor-1 in coronary pathophysiology","volume":"164","author":"Jung","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.034_bib54","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","article-title":"Plasminogen-activator inhibitor type 1 and coronary artery disease","volume":"342","author":"Kohler","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.07.034_bib55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.034_bib56","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/j.1538-7836.2005.01420.x","article-title":"PAI-1 and atherothrombosis","volume":"3","author":"Vaughan","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.034_bib57","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.3324\/haematol.2019.230367","article-title":"Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation","volume":"105","author":"Morrow","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.07.034_bib58","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0002-8703(88)90878-2","article-title":"Impaired fibrinolysis in coronary artery disease","volume":"115","author":"Francis","year":"1988","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2024.07.034_bib59","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/00365519850186274","article-title":"Tissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA\/inhibitor complexes","volume":"58","author":"Nordenhem","year":"1998","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jtha.2024.07.034_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0038-1650232","article-title":"Proteins of the fibrinolytic system in human thrombi","volume":"75","author":"Robbie","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.034_bib61","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood-2004-04-1439","article-title":"Platelets synthesize large amounts of active plasminogen activator inhibitor 1","volume":"104","author":"Brogren","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.034_bib62","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0049-3848(14)50012-6","article-title":"Cancer-related coagulopathies","volume":"133","author":"Levi","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.034_bib63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2019.11.031","article-title":"Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists","volume":"185","author":"Garabet","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.034_bib64","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211054514","article-title":"Endothelial activation and immune thrombocytopenia: an engagement waiting for consolidation","volume":"27","author":"Efat","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.07.034_bib65","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1172\/JCI111789","article-title":"A\u00a0monoclonal antibody to human platelet glycoprotein IIIa detects a related protein in cultured human endothelial cells","volume":"75","author":"Thiagarajan","year":"1985","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.07.034_bib66","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1160\/TH13-10-0873","article-title":"Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia","volume":"112","author":"Alvarez Rom\u00e1n","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.034_bib67","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.thromres.2012.11.021","article-title":"Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura","volume":"131","author":"Sewify","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.034_bib68","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2017-12-768994","article-title":"Exploring traditional and nontraditional roles for thrombomodulin","volume":"132","author":"Loghmani","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.034_bib69","doi-asserted-by":"crossref","first-page":"20705","DOI":"10.1016\/S0021-9258(19)47120-2","article-title":"Regulation of endothelial cell coagulant properties","volume":"264","author":"Scarpati","year":"1989","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.07.034_bib70","first-page":"233","article-title":"Regulation of endothelial cell t-PA synthesis and release","volume":"59","author":"Kooistra","year":"1994","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtha.2024.07.034_bib71","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/09537104.2011.571317","article-title":"Can thrombelastography be a new tool to assess bleeding risk in patients with idiopathic thrombocytopenic purpura?","volume":"22","author":"Gunduz","year":"2011","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2024.07.034_bib72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.hemonc.2020.05.003","article-title":"Rotational thromboelastometry parameters as predicting factors for bleeding in immune thrombocytopenic purpura","volume":"14","author":"Nguyen","year":"2021","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtha.2024.07.034_bib73","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/bjh.12929","article-title":"Beyond the platelet count: immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thrombocytopenia","volume":"166","author":"Greene","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.07.034_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12511","article-title":"Fibrinolysis and bleeding of unknown cause","volume":"5","author":"Mehic","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.034_bib75","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/bloodadvances.2020003464","article-title":"Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency","volume":"5","author":"Mehic","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.07.034_bib76","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1182\/bloodadvances.2020002452","article-title":"Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause","volume":"4","author":"Mehic","year":"2020","journal-title":"Blood Adv"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T21:38:01Z","timestamp":1734557881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624004896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1538783624004896"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.07.034","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrinolysis is impaired in patients with primary immune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}